Source link : https://newshealth.biz/health-news/pirtobrutinibs-star-turn-may-get-an-encore/
In just over a year since its US Food and Drug Administration (FDA) approval, pirtobrutinib (Jayprica) has become a standard therapy for patients with chronic lymphocytic leukemia (CLL) who have developed resistance to other treatments. “Pirtobrutinib has added an entire line of therapy for patients with progression on covalent BTK [Bruton’s tyrosine kinase] inhibitors and […]
The post Pirtobrutinib’s Star Turn May Get an Encore first appeared on News Health.
Author : News Health
Publish date : 2025-03-28 12:10:00
Copyright for syndicated content belongs to the linked Source.